ProFund Advisors »

Cerevel Therapeutics Hldng I shares owned by ProFund Advisors

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by ProFund Advisors from 13F filings

Historical chart of ProFund Advisors investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by ProFund Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.5M 35k 42.27
2023-09-30 $742k 34k 21.83
2023-06-30 $1.0M 33k 31.79
2023-03-31 $959k 39k 24.39

More positions owned by ProFund Advisors

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Qualcomm (QCOM)
Intel Corporation (INTC)
Costco Wholesale Corporation (COST)
Applied Materials (AMAT)
Netflix (NFLX)

View all positions for ProFund Advisors

Top funds holding Cerevel Therapeutics Hldng I

Bain Capital Investors
Perceptive Advisors
venBio Select Advisor
Vanguard Group
BlackRock
Fil
Alpine Associates Management
Paradigm Biocapital Advisors
Pentwater Capital Management
Soros Fund Management
Citigroup
Geode Capital Management
FMR
Baker Bros. Advisors
Millennium Management

View all funds holding Cerevel Therapeutics Hldng I